Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $12.33 +9.02 (+272.51%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$8.31 -4.02 (-32.61%) As of 07/15/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance The Cyclacel Pharmaceuticals (CYCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 97.06%, with a year-to-date return of -86.34%. In the past month, the stock has increased 141.06%, reflecting recent market activity. As of the latest close, Cyclacel Pharmaceuticals traded at $12.33 with a market cap of $19.54 million and volume of 63.34 million shares. Five years ago, the stock traded at a split-adjusted price of $15,984.00, representing a 99.92% decrease over that period. At the time, it had a market cap of $21.34 million and a volume of 30 shares. Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+232.35%1 Month Performance+141.06%3 Month Performance-76.26%Year-To-Date Performance-86.34%1 Year Performance-97.06%5 Year Performance-99.92% CYCC Stock Chart for Wednesday, July, 16, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$3.31$12.33+272.51%$19.25$4.5563.34 million shs$19.54 million07/14/2025$3.71$3.31-10.78%$3.65$3.27134,768 shs$5.25 million07/11/2025$4.20$3.71-11.67%$4.17$3.6881,498 shs$5.88 million07/10/2025$3.73$4.20+12.60%$4.34$3.52234,424 shs$6.64 million07/09/2025$3.36$3.73+11.01%$3.81$3.17233,684 shs$5.89 million07/08/2025$3.57$3.36-5.88%$3.60$3.27237,626 shs$79.83 million07/07/2025$0.23$3.57+1,432.19%$3.97$3.085.35 million shs$84.82 million07/04/2025$3.50$0.23-93.33%$0.25$0.222.59 million shs$5.54 million07/03/2025$3.72$3.50-6.01%$3.75$3.23172,975 shs$5.54 million07/02/2025$5.04$3.72-26.29%$4.35$3.45283,808 shs$5.89 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$4.95$5.04+1.82%$5.10$4.7619,522 shs$7.99 million06/30/2025$4.97$4.95-0.21%$4.95$4.8027,160 shs$7.85 million06/27/2025$5.25$4.97-5.37%$5.30$4.8631,517 shs$7.43 million06/26/2025$5.48$5.25-4.30%$5.55$5.0349,806 shs$7.85 million06/25/2025$5.25$5.48+4.43%$6.11$4.88254,498 shs$8.21 million06/24/2025$4.91$5.25+6.97%$5.25$4.7036,100 shs$7.86 million06/23/2025$5.11$4.91-4.02%$5.10$4.8346,487 shs$7.35 million06/20/2025$5.06$5.11+1.01%$5.54$4.8086,206 shs$7.65 million06/19/2025$5.06$5.06$5.23$4.74115,524 shs$7.58 million06/18/2025$5.26$5.06-3.68%$5.23$4.74115,524 shs$7.58 million06/17/2025$5.12$5.26+2.76%$5.62$4.411.15 million shs$7.87 million06/16/2025$6.18$5.12-17.25%$5.85$4.71153,605 shs$7.66 million Related Companies NanoViricides Stock Chart BioAtla Stock Chart Chemomab Therapeutics Stock Chart VYNE Therapeutics Stock Chart Aytu BioPharma Stock Chart Dare Bioscience Stock Chart Finch Therapeutics Group Stock Chart Relmada Therapeutics Stock Chart Sol-Gel Technologies Stock Chart DURECT Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCC Stock Alerts